Ethyl 2-Chloroacetoacetate CAS 609-15-4 Purità > 99.0% (GC) Febuxostat Fabbrika Intermedja
Ruifu Chemical Supply Febuxostat Intermedji Relatati:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Isem Kimiku | Ethyl 2-Chloroacetoacetate |
Sinonimi | 2-Cloroacetoacetic Aċidu Etil Ester;2-Kloro-3-Ossobutirat ta' l-etil |
Numru CAS | 609-15-4 |
Numru tal-KAT | RF-PI1854 |
Status tal-istokk | Fil-Ħażna, Skala ta' Produzzjoni Sa Tunnellati |
Formula Molekulari | C6H9ClO3 |
Piż Molekulari | 164.59 |
Punt tat-tidwib | -80℃ |
Punt tat-togħlija | 107℃/14 mmHg (mixgħul) |
Densità | 1.19 g/mL f'25℃ (lit.) |
Indiċi rifrattiv | n20/D 1.441 (lit.) |
Brand | Ruifu Kimika |
Oġġett | Speċifikazzjonijiet |
Dehra | Likwidu ċar bla kulur għal isfar ċar |
Purità / Metodu ta 'Analiżi | >99.0% (GC) |
Spettru 1H NMR | Konsistenti mal-Istruttura |
Impuritajiet Totali | <1.00% |
Standard tat-Test | Standard tal-Intrapriża |
Użu | Intermedju ta' Febuxostat (CAS: 144060-53-7) |
Pakkett: Flixkun Fluworinat, 25kg/Barrel, jew skond il-ħtieġa tal-klijent
Kundizzjoni tal-Ħżin:Aħżen f'kontenituri ssiġillati f'post frisk u niexef;Ipproteġi mid-dawl u l-umdità
Ethyl 2-Chloroacetoacetate (CAS: 609-15-4) huwa intermedju importanti ta 'Febuxostat (CAS: 144060-53-7).Febuxostat huwa inibitur ta' xanthine oxidase, klinikament użat biex jikkura iperuriċemija (gotta).Huwa inibitur selettiv ġdid u effettiv ħafna ta 'non-purine xanthine oxidase.Xanthine oxidase hija l-enzima ewlenija biex tippromwovi l-produzzjoni ta 'aċidu uriku.Febuxosutan jista' jnaqqas il-livell ta' aċidu uriku fid-demm ta' pazjenti b'iperuriċemija u gotta.Studji kliniċi wrew li l-mediċina hija sigura u effettiva.Il-mediċina hija metabolizzata mill-fwied u ma tistrieħx fuq l-eskrezzjoni renali.